glutathione vs glucuronic acid Phase II Reactions Pharmacokinetics - Medical Pharmacology and
Description
Molecular mechanism of cholangiocarcinoma carcinogenesis
Transplant Int (2020) 33:83340
Hospira has previously responded to FDA warning letters with facility improvements and corrective action plans that met regulatory requirements
10.1080/00365521.2021.1922744 152 SobhaniI.BergstenE.CouffinS.AmiotA.NebbadB.BarauC.et al (2019)
